CAPTRUST Financial Advisors
HIV

CAPTRUST Financial Advisors’s CALYPTE BIOMEDICAL CORP NEW HIV Stock Holding History

CAPTRUST Financial Advisors’s Portfolio HIV Stock Details HIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-33
Closed – – 5384
2022
Q1 		$0 Buy
+33
New – ﹤0.01% 5372
2018
Q3 		– Sell
-33
Closed – – 1793
2018
Q2 		$0 Hold
33
– – ﹤0.01% 1684
2018
Q1 		$0 Buy
+33
New – ﹤0.01% 1442